Castellón PRM, Hernández PJA, Estrada AA, Chacón SRA, Ríos BM

Language: Spanish
References: 18
Page: 92-98
PDF size: 231.25 Kb.

ABSTRACT

Background: Preeclampsia complicates pregnancy in 3% to 8%, in Mexico it occurs in 5% to 10% of all pregnancies. The world incidence of the severe form all is unknown; however, in United States an incidence of 1% has been reported. Among the causes precipitating birth induction are intrauterine growth restriction, fetal distress and placenta abruption.
Objectives: To determine maternal and fetal complications in women with severe preeclampsia who were admitted to the National Institute of Perinatology, and to establish the indications for birth induction in these women undergoing expectant management between 25 to 32 weeks of gestation.
Patients and method: A retrospective cohort study in which we reviewed the records of all patients diagnosed with severe preeclampsia between 2005 and 2009, and we used those records of women who had a diagnosis of severe preeclampsia at admission and who met criteria for expectant management, the data were collected in a database of art, and then analyzed the different variables in Statistical Package for the Social Sciences (SPSS).
Results: Of the 27 patients studied, the average weeks of gestation on admission was 29.2, 41% were nulliparous as main risk factor, 100% completed lung maturity; the average time of days of expectant management was 3.1 ± 1.3 days (interval: one to seven days). The average gestational age at the birth induction was of 30.1 weeks (interval: 25.2 to 32.5 weeks of gestation). The main criteria for birth induction were: hypertensive crisis (44%), intrauterine growth restriction (30%), hypertensive encephalopathy and epigastric pain (19% each), elevation of transaminases and thrombocytopenia (11%), and oliguria (7%). The way of birth was 96% by caesarean and 4% by vaginal birth.
Conclusion: The main criteria for birth induction in our sample were the uncontrolled blood pressure and intrauterine growth restriction. The time for the extension of the pregnancy was not significant compared with other studies; however, fetal lung maturity was completed.

REFERENCES

1. Sarsam S, Shamden M, Al Wazan R. Expectant versus aggressive management in severe preeclampsia remote from term. Singapore Med J 2008;49:698.

2. Muñoz-Sánchez. Pre eclampsia-eclampsia. Rev Mex Anest 2005;28.

3. Briceño C, Briceño L. Conducta obstétrica basada en evidencias: preeclampsia severa: ¿tratamiento agresivo o expectante? Ginecol Obstet Mex 2007;75: 95-103.

4. Odendaal H, Pattinson R, Bam R, Grove D, Kotze T. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks’ gestation: a randomized controlled trial. Obstet Gynecol 1990;76:1070-1075.

5. Sibai B, Mercer B, Schiff E, Friedman S. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks gestation: a randomized controlled trial. Am J Obstet Gynecol 1994;171:818–822.

6. Roberts J, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension 2003;41:437-445.

7. Diagnosis and management of preeclampsia and eclampsia. American College of Obstetricians and Gynecologist. Practice Bulletin No. 33, 2002.

8. Sibai M, Lipchitz J, Anderson G, Dilts P. Reassement of intravenous MgSO4 therapy in preeclampsia-eclampsia. Obstet Gynecol 1981;57:199-202.

9. Zuspan F. Treatment of severe preeclampsia and eclampsia. Clin Obstet Gynecol 1966;9:954-972.

10. Briones-Garduño J, Díaz M, González-Vargas A, Briones- Vega C. Resultado perinatal con tratamiento conservador en la pre eclampsia-eclampsia. Reporte preliminar. Cir Ciruj 2003;71:112-115.

11. Sibai M, Barton J. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol 2007;196:514-519.

12. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2000.

13. Shear R, Rinfret D, Leduc L. Should we offer expectant management in cases of severe preterm preeclampsia with fetal growth restriction? Am J Obstet Gynecol 2005;192:1119-1125.

14. Churchill D, Duley l. Conducta activa versus expectante para la preeclampsia severa antes de término. The Cochrane Library, 2006.

15. Norwitz E, Edmund F, Funai A. Expectant management of severe preeclampsia remote from term: hope for the best, but expect the worst. Am J Obstet Gynecol 2008;199:209-12.

16. Vigil P, Montufar-Rueda C, Ruiz J. Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks gestation. Euro J Obstet Gynecol Reprod Bio 2002;107:24-27.

17. Bassam H, Deis S, Goffinet F, Paniel B, et al. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks gestation. Am J Obstet Gynecol 2004;190:1590-1595.

18. Bombrys A, Barton J, Habli M, Sibai M. Expectant management of severe preeclampsia at 27-33.6 weeks gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Perinatol 2009;26:441-446.